007460 — Aprogen Income Statement

0.000.00%

Last trade - 00:00

IndustrialsHighly SpeculativeSmall CapSucker Stock

Market Cap
KR₩361bn
Enterprise Value
KR₩714bn
Revenue
KR₩151bn

Annual income statement for Aprogen, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	78,249	127,143	141,247	78,349	150,578
Cost of Revenue
Gross Profit	19,355	34,465	31,250	6,153	35,808
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	31,409	123,416	146,426	189,910	243,057
Operating Profit	46,840	3,727	-5,179	-111,560	-92,479
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	16,923	-39,117	-9,182	-115,611	-95,239
Provision for Income Taxes
Net Income After Taxes	16,575	-32,668	-12,500	-116,085	-97,283
Minority Interest
Net Income Before Extraordinary Items
Net Income	11,712	-46,490	-18,002	-98,657	-55,619
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	11,712	-46,490	-18,002	-98,657	-55,619
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-374	-819	-255	-515	-226
Dividends per Share